This is actually the same interview from two weeks ago (below), but a good overview. The next few weeks should be very interesting, and then more data to come in Jan and Feb. Here's the general timeline given from the Nov 14 conference call. The key (imo) will be the 94 day data -
Dec ------------ Sustained Clinical Cure data
Dec or Jan --- Extended Clinical Cure data up to 94 days
Jan or Feb --- Impact on Microbiome data
March --------- End of Phase 2 meeting with FDA
Summary - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173224909
---
Recent ACXP News
- Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference • PR Newswire (US) • 05/02/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference • PR Newswire (US) • 04/25/2024 02:12:00 PM
- Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update • PR Newswire (US) • 04/23/2024 02:57:00 PM
- Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More • IH Market News • 03/19/2024 11:33:10 AM
- Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks • IH Market News • 03/18/2024 11:12:12 AM
- Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update • PR Newswire (US) • 03/18/2024 11:01:00 AM
- Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update • PR Newswire (US) • 03/04/2024 12:01:00 PM
- Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development • PR Newswire (US) • 02/27/2024 12:01:00 PM
- New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series • GlobeNewswire Inc. • 02/23/2024 02:30:00 PM
- New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 02/16/2024 02:30:00 PM
- New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT • GlobeNewswire Inc. • 02/02/2024 02:30:00 PM
- New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT • GlobeNewswire Inc. • 02/01/2024 02:33:37 PM
- Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients • PR Newswire (US) • 01/29/2024 12:00:00 PM
- New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 01/26/2024 03:55:40 PM
- Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024 • PR Newswire (US) • 01/23/2024 12:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 11:15:17 AM
- New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 01/19/2024 02:30:00 PM
- Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients • PR Newswire (US) • 01/17/2024 12:01:00 PM
- New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 01/05/2024 02:30:00 PM
- Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/03/2024 01:00:00 PM
- Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure • PR Newswire (US) • 12/11/2023 12:01:00 PM
- New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT • GlobeNewswire Inc. • 12/08/2023 02:46:51 PM
- New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT • GlobeNewswire Inc. • 12/07/2023 02:20:44 PM
- New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT • GlobeNewswire Inc. • 12/01/2023 02:30:00 PM
- New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT • GlobeNewswire Inc. • 11/24/2023 02:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM